# Filing Detail

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-25-041663
Filing Date
2025-05-12
Accepted
2025-05-09 19:58:51
Documents
180
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT NO. 1 TO FORM 20-F | ea0241374-20fa1_adlai.htm iXBRL | 20-F/A | 3311660
2 | CERTIFICATION | ea024137401ex12-1_adlai.htm | EX-12.1 | 12371
3 | CERTIFICATION | ea024137401ex12-2_adlai.htm | EX-12.2 | 12485
4 | CERTIFICATION | ea024137401ex13-1_adlai.htm | EX-13.1 | 5158
5 | CERTIFICATION | ea024137401ex13-2_adlai.htm | EX-13.2 | 5095
6 | CONSENT OF BDO CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LLP | ea024137401ex15-1_adlai.htm | EX-15.1 | 4011
7 | CONSENT OF MAZARS USA LLP | ea024137401ex15-2_adlai.htm | EX-15.2 | 1715
13 | GRAPHIC | image_001.jpg | GRAPHIC | 27955
14 | GRAPHIC | image_002.jpg | GRAPHIC | 39601
15 | GRAPHIC | image_003.jpg | GRAPHIC | 12354
16 | GRAPHIC | image_004.jpg | GRAPHIC | 22375
17 | GRAPHIC | image_005.jpg | GRAPHIC | 25780
18 | GRAPHIC | image_006.jpg | GRAPHIC | 15602
19 | GRAPHIC | image_007.jpg | GRAPHIC | 15798
20 | GRAPHIC | image_008.jpg | GRAPHIC | 16185
21 | GRAPHIC | image_009.jpg | GRAPHIC | 62510
22 | GRAPHIC | image_010.jpg | GRAPHIC | 10673
23 | GRAPHIC | image_011.jpg | GRAPHIC | 33450
24 | GRAPHIC | image_012.jpg | GRAPHIC | 51374
25 | GRAPHIC | image_013.jpg | GRAPHIC | 33230
26 | GRAPHIC | image_014.jpg | GRAPHIC | 15337
27 | GRAPHIC | image_015.jpg | GRAPHIC | 23197
28 | GRAPHIC | image_016.jpg | GRAPHIC | 13053
29 | GRAPHIC | image_017.jpg | GRAPHIC | 20810
30 | GRAPHIC | image_018.jpg | GRAPHIC | 22401
31 | GRAPHIC | image_019.jpg | GRAPHIC | 23349
32 | GRAPHIC | image_020.jpg | GRAPHIC | 130254
33 | GRAPHIC | fin_001.jpg | GRAPHIC | 11844
34 | GRAPHIC | ex15-1_001.jpg | GRAPHIC | 40354
| Complete submission text file | 0001213900-25-041663.txt |  | 15482962

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | anl-20241231.xsd | EX-101.SCH | 165144
9 | XBRL CALCULATION FILE | anl-20241231_cal.xml | EX-101.CAL | 85714
10 | XBRL DEFINITION FILE | anl-20241231_def.xml | EX-101.DEF | 590512
11 | XBRL LABEL FILE | anl-20241231_lab.xml | EX-101.LAB | 994865
12 | XBRL PRESENTATION FILE | anl-20241231_pre.xml | EX-101.PRE | 615505
184 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0241374-20fa1_adlai_htm.xml | XML | 2058415

Mailing Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902
Business Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902 848-230-7430
Adlai Nortye Ltd. (Filer) CIK: 0001944552 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-41773 | Film No.: 25932264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)